Institute of Human Genetics including dementia with Lewy bodies (DLB) and multiple
fected individuals who were genotyped, only two were older than 60 years of age and were mutation carriers. These individuals are considered to be at risk and likely Results presymptomatic, given that the average age of onset in this family is 65 years (Wszolek et al., 2004) . To protect Within our linked families, haplotype analysis of obligate recombinants initially refined a candidate region of 13 the confidentiality of family members, some pedigree symbols and genotypes have been omitted and gender Mb, between flanking markers D12S1692 and D12S85. We subsequently sequenced a total of 29 genes in the has been disguised in the pedigrees (Figure 1) . To estimate the prevalence of LRRK2 mutations region, in two patients from each family. Supplemental Table S1 (Figure 3B) . The expression pattern of LRRK2 was subsequently examined in several tissues. We hybridized human brain and multiple tissue Northern blots with a 1078 bp 3Ј cDNA probe and found expression in most brain regions, albeit at very low levels. There appeared to be a major transcript of 9 kb and a minor transcript of ‫8ف‬ kb, which may be explained by the alternative use of polyadenylation [poly(A)] sites. This would be in concordance with two mRNAs, deposited under the accession numbers AL832453 and AL834529, which make use of splicing. We designed primers to generate specific PCR products for exons 1-3, exons 12-13, and exons 32-34, and pathological details of affected patients within these respectively. Within the same tissue or brain region, smaller families are illustrated in Figure 2 . Clinical and transcript levels of all three assays showed no signifigenetic information for all families with LRRK2 mutations cant differences. We found low, but consistent, expresis summarized in Table 1 ease. In the final individual, there were tau-immunoreactive neuronal and glial lesions that morphologically resembled lesions of PSP; however, the density and distribution of the lesions was not diagnostic of PSP. Alzheimer type pathology, which might be expected given the advanced age at autopsy, was detected in several individuals, and one met neuropathologic criteria for Alzheimer's disease. Several individuals in family A had clinical features of motor neuron disease, and there was mild decrease of anterior horn cells, gliosis, and axonal spheroids in these cases (Wszolek et al.,  1997) .
Discussion
Although only a small proportion of PD cases are caused by gene mutations with high penetrance, identification of these genes has had a major impact on the understanding of the molecular mechanisms leading to dopaminergic neurodegeneration. Those mechanisms include the aggregation of proteins such as ␣-synuclein and tau, deficits in ubiquitin-proteasome protein degradation, or mitochondrial dysfunction and oxidative stress. Until now, it was assumed that these represented separate molecular pathways, all eventually leading to neuronal death, but originating from different initial insults. This view will need to be revised given the present findings.
LRRK2 appears to be central to the etiology of not just one but several neurodegenerative diseases, including those associated with ␣-synuclein and tau pathology 
␣-synuclein pathology, including Lewy bodies and Lewy
Genomic DNA from peripheral blood lymphocytes was extracted using standard protocols. Blood was collected after obtaining inneurites, in a pattern typical of diffuse Lewy body dis-formed consent from all participating family members. All human quantified using the h-PBGD Housekeeping Gene Set (RocheApplied Science). Relative transcript levels were calculated as ratios studies are approved by institutional review boards of participating institutions.
of LRRK2/PBGD normalized to adult whole brain adult expression as 100%. Sequence Analysis Genomic sequences and annotations were obtained from the National Center for Biotechnology Information (NCBI) (http://www.
